Your browser doesn't support javascript.
loading
An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study.
Waldock, Joanna; Weiss, Carol D; Wang, Wei; Levine, Min Z; Jefferson, Stacie N; Ho, Sammy; Hoschler, Katja; Londt, Brandon Z; Masat, Elisa; Carolan, Louise; Sánchez-Ovando, Stephany; Fox, Annette; Watanabe, Shinji; Akimoto, Miki; Sato, Aya; Kishida, Noriko; Buys, Amelia; Maake, Lorens; Fourie, Cardia; Caillet, Catherine; Raynaud, Sandrine; Webby, Richard J; DeBeauchamp, Jennifer; Cox, Rebecca J; Lartey, Sarah L; Trombetta, Claudia M; Marchi, Serena; Montomoli, Emanuele; Sanz-Muñoz, Iván; Eiros, José María; Sánchez-Martínez, Javier; Duijsings, Danny; Engelhardt, Othmar G.
Afiliação
  • Waldock J; Vaccines, Science Research & Innovation, Medicines and Healthcare Products Regulatory, Potters Bar, United Kingdom.
  • Weiss CD; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States.
  • Wang W; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States.
  • Levine MZ; Influenza Division, Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, United States.
  • Jefferson SN; Influenza Division, Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, United States.
  • Ho S; Respiratory Viruses Unit, UK Health Security Agency, Colindale, United Kingdom.
  • Hoschler K; Respiratory Viruses Unit, UK Health Security Agency, Colindale, United Kingdom.
  • Londt BZ; hVivo The Queen Mary Bioenterprises (QMB) Innovation, London, United Kingdom.
  • Masat E; hVivo The Queen Mary Bioenterprises (QMB) Innovation, London, United Kingdom.
  • Carolan L; World Health Organisation (WHO) Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Sánchez-Ovando S; World Health Organisation (WHO) Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Fox A; Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Watanabe S; World Health Organisation (WHO) Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Akimoto M; Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Sato A; Center for Influenza and Respiratory Virus Research, National Institute of Infectious Diseases: Musashi-Murayama, Tokyo, Japan.
  • Kishida N; Center for Influenza and Respiratory Virus Research, National Institute of Infectious Diseases: Musashi-Murayama, Tokyo, Japan.
  • Buys A; Center for Influenza and Respiratory Virus Research, National Institute of Infectious Diseases: Musashi-Murayama, Tokyo, Japan.
  • Maake L; Center for Influenza and Respiratory Virus Research, National Institute of Infectious Diseases: Musashi-Murayama, Tokyo, Japan.
  • Fourie C; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases (NICD) of the National Health Laboratory Services, Johannesburg, South Africa.
  • Caillet C; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases (NICD) of the National Health Laboratory Services, Johannesburg, South Africa.
  • Raynaud S; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases (NICD) of the National Health Laboratory Services, Johannesburg, South Africa.
  • Webby RJ; Department of Research and Development, Sanofi, Lyon, France.
  • DeBeauchamp J; Department of Research and Development, Sanofi, Lyon, France.
  • Cox RJ; Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, United States.
  • Lartey SL; Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, United States.
  • Trombetta CM; Influenza Centre, Department of Clinical Sciences, University of Bergen, Bergen, Norway.
  • Marchi S; Influenza Centre, Department of Clinical Sciences, University of Bergen, Bergen, Norway.
  • Montomoli E; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
  • Sanz-Muñoz I; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
  • Eiros JM; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
  • Sánchez-Martínez J; National Influenza Centre of Valladolid, Instituto de Estudios de Ciencias de la Salud de Castilla y León (ICSCYL), Edificio Rondilla, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
  • Duijsings D; National Influenza Centre of Valladolid, Instituto de Estudios de Ciencias de la Salud de Castilla y León (ICSCYL), Edificio Rondilla, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
  • Engelhardt OG; National Influenza Centre of Valladolid, Instituto de Estudios de Ciencias de la Salud de Castilla y León (ICSCYL), Edificio Rondilla, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
Front Immunol ; 14: 1129765, 2023.
Article em En | MEDLINE | ID: mdl-36926342
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Temas: ECOS / Aspectos_gerais Bases de dados: MEDLINE Assunto principal: Influenza Humana Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Temas: ECOS / Aspectos_gerais Bases de dados: MEDLINE Assunto principal: Influenza Humana Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido